Bedaquilinepretomanidmoxifloxacinpyrazinamide for drugsensitive and drugresistant pulmonary tuberculosis treatment a phase 2c openlabel multicentre partially randomised controlled trial

Simple item page
dc.article.end-page3099en
dc.article.start-page1473en
dc.citation.doi10.1016/S1473-3099(24)00223-8en
dc.contributor.authorMuge Ceviken
dc.contributor.authorLindsay C Thompsonen
dc.contributor.authorCaryn Uptonen
dc.contributor.authorValeria Cavalcanti Rollaen
dc.contributor.authorMohammed Rassoolen
dc.contributor.authorFrancesca CONRADIEen
dc.date.accessioned2025-04-09T09:05:44Z
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationWOSen
dc.identifier.issn1473-3099en
dc.identifier.urihttps://hdl.handle.net/10539/44651
dc.journal.titleBedaquilinepretomanidmoxifloxacinpyrazinamide for drugsensitive and drugresistant pulmonary tuberculosis treatment a phase 2c openlabel multicentre partially randomised controlled trialen
dc.journal.volume24en
dc.publisherELSEVIER SCIENCE INCen
dc.titleBedaquilinepretomanidmoxifloxacinpyrazinamide for drugsensitive and drugresistant pulmonary tuberculosis treatment a phase 2c openlabel multicentre partially randomised controlled trialen
dc.typeJournal Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Journal Article.pdf
Size:
665.77 KB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client
Download

Collections

Academic Wits Research Outputs (All submissions)